Followers | 9 |
Posts | 750 |
Boards Moderated | 0 |
Alias Born | 10/19/2008 |
Friday, February 14, 2014 2:31:12 PM
It was basically as follows:
Dear M. Kimelman,
I found your article on Seeking Alpha interesting and timely.
I am a very small investor. As part of my rather minuscule portfolio, I own a small amount of NanoViricides Inc. (NNVC). I have felt personally damaged by Seeking Alpha’s facilitation of anf the platform they gave to an anonymous writer under the pseudonym of the Pump Terminator.
NNVC is not absolutely perfect in their operations. I know of no company that is. All companies undergo growing pains and new cercumstances that might otherwise have altered their approaches. However, I have followed them for years and believe them to be quite genuine, with good goals in mind and often much more respect for their shareholders than many other companies I have investigated in 40 years of investing.
The recent Seeking Alpha article on NNVC being a house of cards strongly accuses them of wrongdoing and the scamming of investors. It was a hit piece pure and simple. I strongly suspect a crime has been committed and that Seeking Alpha is culpable in addition to the nameless author. This resulted in a significant share price drop and fuels deleterious misinformation about the company and its technology.
The sad aspect is that I believe that NNVC has a remarkable gift to humankind. I have studied science and technology for over 40 years as well. I have designed complex systems and executed million dollar R&D projects. While not in the medical field, I have ties and interest there as well. The Street recently had a short advisor that NNVC could be a stock to watch to triple or more. Making money, however, was not my entire reason for investing in it. The effectiveness of their approach to destroy a viral attack on a biological system is utterly amazing. Notable researchers in medicine, such as Dr. Eva Harris, and others have been quite impressed. Data from lethal animal models shows phenomenal efficacy. Their approach could be 1000x more effective that currently available anti-viral medications. Toxicity appears low to non-existent (properly performed TOX studies are still needed to confirm). The additional amazing aspect is that they can quickly tailor the product to destroy nearly any identifiable virus.
Damaging the ability of this company to pursue its discoveries and potential products is an assault not only on its principals and its stakeholders, but on humanity itself.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM